Free Trial Information
BioCentury | May 7, 2016
Financial News

ACT Genomics raises $12.5M series B

Diagnostics developer ACT Genomics Co. Ltd. (Taipei City, Taiwan) raised $12.5 million in a series B round led by Hotung Group and CDIB Capital Management. Existing investors including the Eminent II fund of TaiAn Technologies,...
Read More
BioCentury | Oct 15, 2012
Company News

Compendia Bioscience, Life Technologies deal

...its plan to move into cancer diagnostics, which began in July with the acquisitions of Pinpoint Genomics Inc....
Read More
BioCentury | Oct 15, 2012
Finance

Highlights of weekly biotech stock moves

...a plan to move into cancer diagnostics that began in July with the acquisitions of Pinpoint Genomics Inc....
Read More
BioCentury | Oct 9, 2012
Company News

Life Tech acquires bioinformatics firm Compendia

...its plan to move into cancer diagnostics, which began in July with the acquisitions of Pinpoint Genomics Inc....
Read More
BioCentury | Oct 1, 2012
Company News

Life Technologies sales and marketing update

...at Life Technologies' CLIA-certified laboratory. The company gained the assay through its July acquisition of Pinpoint Genomics Inc....
Read More
BioCentury | Feb 6, 2012
Clinical News

Pinpoint Dx Lung Assay diagnostic data

...of blinded validation studies in FFPE tumor samples from patients with non-squamous NSCLC showed that Pinpoint Genomics'...
...Lancet. The test is available through Pinpoint Genomics' CLIA-certified laboratory in most states in the U.S. Pinpoint Genomics Inc....
Read More
BioCentury | Feb 6, 2012
Company News

Pinpoint Genomics sales and marketing update

...removal surgery. The assay measures the activity levels of 14 genes within a tumor sample. Pinpoint Genomics Inc....
Read More
Items per page:
1 - 7 of 7
BioCentury | May 7, 2016
Financial News

ACT Genomics raises $12.5M series B

Diagnostics developer ACT Genomics Co. Ltd. (Taipei City, Taiwan) raised $12.5 million in a series B round led by Hotung Group and CDIB Capital Management. Existing investors including the Eminent II fund of TaiAn Technologies,...
Read More
BioCentury | Oct 15, 2012
Company News

Compendia Bioscience, Life Technologies deal

...its plan to move into cancer diagnostics, which began in July with the acquisitions of Pinpoint Genomics Inc....
Read More
BioCentury | Oct 15, 2012
Finance

Highlights of weekly biotech stock moves

...a plan to move into cancer diagnostics that began in July with the acquisitions of Pinpoint Genomics Inc....
Read More
BioCentury | Oct 9, 2012
Company News

Life Tech acquires bioinformatics firm Compendia

...its plan to move into cancer diagnostics, which began in July with the acquisitions of Pinpoint Genomics Inc....
Read More
BioCentury | Oct 1, 2012
Company News

Life Technologies sales and marketing update

...at Life Technologies' CLIA-certified laboratory. The company gained the assay through its July acquisition of Pinpoint Genomics Inc....
Read More
BioCentury | Feb 6, 2012
Clinical News

Pinpoint Dx Lung Assay diagnostic data

...of blinded validation studies in FFPE tumor samples from patients with non-squamous NSCLC showed that Pinpoint Genomics'...
...Lancet. The test is available through Pinpoint Genomics' CLIA-certified laboratory in most states in the U.S. Pinpoint Genomics Inc....
Read More
BioCentury | Feb 6, 2012
Company News

Pinpoint Genomics sales and marketing update

...removal surgery. The assay measures the activity levels of 14 genes within a tumor sample. Pinpoint Genomics Inc....
Read More
Items per page:
1 - 7 of 7